Expression of the COVID‐19 receptor ACE2 in the human conjunctiva

SARS‐CoV‐2 is assumed to use angiotensin‐converting enzyme 2 (ACE2) and other auxiliary proteins for cell entry. Recent studies have described conjunctival congestion in 0.8% of patients with laboratory‐confirmed severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2), and there has been specul...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Med Virol
Autori principali: Lange, Clemens, Wolf, Julian, Auw‐Haedrich, Claudia, Schlecht, Anja, Boneva, Stefaniya, Lapp, Thabo, Horres, Ralf, Agostini, Hansjürgen, Martin, Gottfried, Reinhard, Thomas, Schlunck, Günther
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2020
Soggetti:
Research Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7267303/
https://ncbi.nlm.nih.gov/pubmed/32374427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.25981
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi